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Abstract
Background: Cysteine cathepsins (CTSs) are involved in the degradation and remodeling of the extracellular matrix
and are associated with cell transformation, differentiation, motility, and adhesion. These functions are also related
to cancer cell invasion and metastasis. Chickens spontaneously develop epithelial ovarian cancer and are therefore
a good animal model for human ovarian cancer. However, no studies have investigated the expression of CTSs in
chickens with ovarian cancer.
Methods: Cancerous (n = 5) and normal (n = 3) ovaries were collected from 2-to 3-year-old hens, and ovarian
tissue samples were collected for study. Ovarian cancers were evaluated with hematoxylin and eosin staining.
Reverse transcriptase and quantitative PCR analyses, in situ hybridization analysis were performed to examine the
mRNA expression pattern of three CTSs in detail, and protein expression of CTSB was evaluated.
Results: The CTSB, CTSC, and CTSS genes were highly expressed in cancerous chicken ovaries. Messenger RNAs for
the three CTSs were localized to a nodule area, a major characteristic of cancerous ovaries, but the three CTSs
showed no specific localization in normal ovaries. Immunoreactive CTSB protein was present in the nodule area of
cancerous ovaries.
Conclusion: Our results suggest that CTSB, CTSC, and CTSS have important functions in the development of
epithelial ovarian cancer.
Background
Ovarian cancer has the highest mortality rate of all
gynecological cancers and is the fifth leading cause of
death among women [1]. About 90% of human ovarian
cancers are thought to originate from the ovarian sur-
face epithelium [2]. The rate of epithelial ovarian cancer
is high because incessant ovulation causes genomic
damage to the ovarian surface epithelium, increasing the
possibility of gene mutations [3,4]. The lack of an
appropriate animal model has prevented mechanistic
studies of ovarian cancer [2].
Chickens ovulate almost every day, whereas women
ovulate only once a month. Given the prevalent hypoth-
esis that the cause of ovarian cancer is incessant ovula-
tion [5], chickens that spontaneously develop epithelial
ovarian cancer may be a good animal model for
researching the mechanisms responsible for human
ovarian cancer [6,7]. Furthermore, CA125, a well-known
marker for human ovarian cancer, is expressed in
chicken ovarian cancer cells, but not in normal ovarian
cells [6,8,9].
There are 11 cysteine cathepsins in human (CTSB, -C,
-F, -H, -K, -L, -O, -S, -V, -W, and -X/Z), which all share
a conserved active site formed by cysteine and histidine
residues [10]. The CTSs have functions in not only reg-
ulation of intracellular protein metabolism [11] but also
bone resorption [12] and antigen presentation [13]. In
addition, CTSs are involved in the degradation and
remodeling of extracellular matrix and are associated
with cell transformation, differentiation, motility, and
adhesion [14]. These functions are also related to cancer
cell invasion and metastasis [15,16]. CTSB is a marker
for ovarian cancer prognosis [17] and may contribute to
the invasion of ovarian cancer cells [18]. Nevertheless,
no studies have investigated the expression of CTSs in
chickens with ovarian cancer.
The purpose of this study is to confirm that the
expression pattern of CTSs in human is replicated to
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all known CTSs was examined in normal and cancerous
ovaries from chickens, and in situ hybridization was
used to determine the cell-specific localization of CTSs
differentially expressed between normal and cancerous
ovaries.
Methods
Animals
The care and experimental use of White Leghorn (WL)
chickens was approved by the Institute of Laboratory
Animal Resources, Seoul National University (SNU-
070823-5). The WL chickens were maintained in a stan-
dard management program at the University Animal
Farm, Seoul National University, Korea. The procedures
for animal management, reproduction, and embryo
manipulation followed standard operating protocols
used in our laboratory.
Tissue samples
Cancerous (n = 5) and normal (n = 3) ovaries were col-
lected from 2-to 3-year-old WL hens, and ovarian tissue
samples were collected for study. We have examined the
tumor stage in five chickens with cancerous ovaries
according to characteristic features of chicken ovarian
cancer previously reported [19]. In three hens, ovarian
tumor seeding had metastasized to gastrointestinal tract
and superficial surface in liver, and profuse ascites were
detected in abdominal cavity. In the other two hens, the
tumors had metastasized to distant organs with profuse
ascites such as liver parenchyma, lung, gastrointestinal
tract and oviduct. Therefore, former three and later two
tumors were classified to the stage III and stage IV of
chicken ovarian cancer, respectively. Subsets of these
samples were frozen or paraffin-embedded for further
analyses. Paraffin-embedded tissues were sectioned at 5
μm and stained with hematoxylin and eosin (H&E).
Epithelial ovarian cancers in chicken were classified
based on the cellular subtypes and patterns of cellular
differentiation with reference to ovarian malignant
tumor types in humans. In this study, three types
including serous (n = 2), endometrioid (n = 2), and
clear cell (n = 1) were observed in chicken ovarian
tumors.
RT-PCR analysis
Total RNA was extracted from frozen tissues by Trizol
reagent (Invitrogen, Carlsbad, CA), and cDNAs were
synthesized using AccuPower® RT PreMix (Bioneer,
Daejeon, Korea). The cDNA was serially diluted 10-fold
and quantitatively equalized for PCR amplification using
specific primer sets (Table 1). The PCR amplification
was performed as follows: 1) 95°C for 3 min; 2) 95°C for
20 s, 60°C for 40 s, and 72°C for 1 min for 30 cycles
(CTSS and GAPDH), 35 cycles (CTSB, CTSC, CTSH,
CTSK, CTSL,a n dCTSZ), or 40 cycles (CTSO); and 3)
72°C for 5 min. The PCR products were analyzed using
1% agarose gels with ethidium bromide.
Quantitative RT-PCR analysis
Quantitative RT-PCR was performed using SYBR Green
(Sigma, St. Louis, MO) and a StepOnePlus Real-Time
PCR System (Applied Biosystems, Foster City, CA). Rela-
tive quantification of gene expression was calculated using
the formula 2
-ΔΔCt ,w h e r eΔΔCt = (Cttarget gene -C t GAPDH)
cancerous tissue -( C t target gene -C t GAPDH)normal tissue.T h e
information for the primer sets is provided in Table 2.
In situ hybridization analysis
The expression of selected genes was examined using in
situ hybridization as previously described [20]. For
hybridization probes, PCR products were generated
from ovarian cancer cDNA with the primers used for
Table 1 Primers used for RT-PCR
Gene Sequence (5′!3′): GenBank Product
Size (bp)
Forward and Reverse Accession No.
CTSB AGGGCACAACTTCCACAACA
GCGAGTAGCCAGGTTCACAG
NM_205371.1 524
CTSC AAAGCCTGCCCCTCTAACAC
AGCCTACCAGCAAGACAGCA
XM_417207.2 590
CTSH GGGGCTTTTTAGTGGCTCTG
GAAGTCGCTCGTCACCTCAA
XM_001232764.1#1 560
CTSK GAGGAGGTGGTGAGGACGAT
AGAACTGGAAGGAGGGCAGA
NM_204971.1 526
CTSL CCTGATTTGGACAGCCACTG
AGCCTTGATTTCCTTCTGGG
NM_001168009.1 475
CTSO AGTGCCAAAGGGAGAGGAAA
CAAAGGACCCCAGTCAACAA
NM_001031129.1 427
CTSS GCACCCTCAACGAGAAGGA
GCACAGAGAAAATCACCCCC
NM_001031345.1 433
CTSZ GTCAACTACGCCAGCACCAC
CATTTTCTACACCCCAGCCA
XM_417483.2 538
GAPDH CACAGCCACACAGAAGACGG
CCATCAAGTCCACAACACGG
NM_204305 443
Table 2 Primers used for quantitative RT-PCR
Gene Sequence (5′!3′): GenBank Product Size
(bp)
Forward and Reverse Accession No.
CTSB GCACTACGGCATCACATCCT
AACCTGCTCCCCTGACACAT
NM_205371.1 157
CTSC CTGGAGAAATGTGAATGGCG
CTGGGGACTGAAGACTGGCT
XM_417207.2 151
CTSS TGCCACGTGCTCCAAGTATG
CGTGGTTCACCTCCTGTGTG
NM_001031345.1 173
GAPDH ACACAGAAGACGGTGGATGG
GGCAGGTCAGGTCAACAACA
NM_204305 193
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cloned into pGEM-T Easy Vector (Promega). All plas-
mids were sequenced using T7 and SP6 primers to cer-
tain the genes as expected. After verification of the
sequences, a DIG-labeled RNA probe was prepared
using a DIG RNA labeling kit (Roche Applied Science,
Indianapolis, IN). Frozen sections (10 μm) were
mounted on slides pretreated with 3-aminopropyl-
triethoxysilane (APES, Sigma), dried on a 50°C slide
warmer, and fixed in 4% paraformaldehyde in phos-
phate-buffered saline (PBS). The sections were treated
with 1% Triton X-100 in PBS for 20 min and washed
three times in PBS. The sections were incubated in a
prehybridization mixture containing 50% formamide and
5 × standard saline citrate (SSC) for 15 min at room
temperature. After prehybridization, the sections were
incubated with a hybridization mixture containing 50%
formamide, 5 × SSC, 10% dextran sulfate sodium salt,
0.02% bovine serum albumin, 250 μg/ml yeast tRNA,
and denatured DIG-labeled cRNA probe for 18 h at 55°
C in a humidified chamber. The sections were washed
for stringency in a series of solutions containing forma-
mide and SSC. After blocking with a 1% blocking
reagent (Roche), the sections were incubated overnight
with sheep anti-DIG antibody conjugated to alkaline
phosphatase (Roche). The signal was visualized by expo-
sure to a solution containing 0.4 mM 5-bromo-4-
chloro-3-indolyl phosphate, 0.4 mM nitroblue tetrazo-
lium, and 2 mM levamisole (Sigma). All sections were
counterstained with 1% (w/v) methyl green (Sigma), and
photographs were taken using a Zeiss Axiophot light
microscope equipped with an Axiocam HRc camera
(Carl Zeiss).
Immunohistochemistry
The candidate hens with either normal or cancerous
ovaries were sacrificed, and their ovaries were collected
and fixed in 4% paraformaldehyde. The tissues were
embedded in paraffin and sectioned at 5 μmo nA P E S -
treated (silanized) slides. The sections were then
deparaffinized in xylene and rehydrated to water
through a graded series of alcohol. After antigen retrie-
val by boiling in a citrate buffer (10 mM), the sections
were incubated with either mouse anti-PCNA IgG
(monoclonal antibody raised against recombinant rat
PCNA, Santa Cruz Biotechnology, Santa Cruz, CA),
mouse anti-vimentin IgG (monoclonal antibody raised
against vimentin purified form bovine lens, Millipore,
Billerica, MA), mouse anti-ERBB2 IgG (monoclonal
antibody raised against a synthetic peptide from the C-
terminus of human ERBB2 protein, Thermo Fisher
Scientific, Waltham, MA), or rabbit anti-CTSB IgG
(polyclonal antibody raised against recombinant rat
procathepsin B, Millipore). Mouse and rabbit IgG were
used as negative controls. All antibodies were used at
2 μg/ml in PBS containing 1% BSA. The slides were
then treated with an avidin-biotin-peroxidase complex
according to the manufacturer’si n s t r u c t i o n s( V e c t o r
Laboratories, Burlingame, CA) and visualized using
diaminobenzidine tetrahydrochloride (Sigma) as a color
substrate. After visualization, the sections were cover-
slipped using Permount (Fisher Scientific, Pittsburgh,
PA).
Statistical analyses
All statistical analyses were performed using Student’st
test using the SAS program (SAS Institute, Cary, NC,
USA). Differences were considered significant at a value
of P < 0.05.
Results
Pathological characteristics of chicken ovarian cancer
Cancerous ovaries from chickens differed morphologi-
cally from normal ovaries. The normal chicken ovary
contained large yellow follicles that were hierarchically
arranged by stage (Fig. 1A). However, the cancerous
ovary was more solid and possessed surface tumor
lesions and atretic follicles, indicating abnormal ovarian
function (Fig. 1B). Further histological analysis after
H&E staining of normal and cancerous ovaries revealed
that normal ovaries contained follicles surrounded by
connective tissue (Fig. 1C), whereas cancerous ovaries
consisted primarily of nodule structures in the solid por-
tion of the ovary (Fig. 1D). These morphological differ-
ences between normal and cancerous ovaries were very
similar to those reported previously [21-24].
Immunohistochemical characterization of chicken ovarian
cancer
We performed immunohistochemistry to further charac-
terize cancerous chicken ovaries based on reports that
proliferating cell nuclear antigen (PCNA), vimentin, and
ERBB2 proteins were detected in cancerous ovaries of
chickens [8,25,26]. In the present study, immunoreactive
PCNA was detected in granulosa cells surrounding folli-
cles in normal ovaries (Fig. 2A and 2B), and vimentin
was localized to the cells surrounding the granulosa cell
layer and blood vessels (Fig. 2C and 2D). ERBB2 was
also weakly expressed in glands and blood vessels (Fig.
2E and 2F). In cancerous ovaries, PCNA protein was
predominantly detected in the nucleus of cancerous
cells in the nodule area (Fig. 2G and 2H). However,
vimentin was not expressed in cancerous areas of the
ovaries, but was detected in blood vessels (Fig. 2I and
2J). ERBB2 was localized to the cytoplasm in the nodule
area of cancerous ovaries (Fig. 2K and 2L).
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and cancerous ovaries
Based on the morphological and immunohistochemical
differences between normal and cancerous hen ovaries,
we hypothesized that expression patterns of the various
CTSs related to cancer may differ between normal and
cancerous tissues. First, the expression of all known
CTSs in cancerous chicken ovaries was examined by
RT-PCR analysis, and six CTSs were found to be
expressed in both normal and cancerous ovaries (Fig. 3).
CTSH and CTSK were not detected by RT-PCR (data
not shown).
In situ hybridization analysis was used to determine
cell-specific localization of CTSB, CTSC,a n dCTSS
mRNAs (Fig. 4). CTSB was expressed at a low level
around follicles in the normal ovaries, but there was
strong expression of CTSB mRNA in the nodule area in
cancerous ovaries. Similarly, there was localization of
CTSC mRNA around follicles in normal ovaries,
whereas CTSC mRNA was weakly expressed in the
nodule area of cancerous ovaries. Although there was
also localization of CTSS mRNA around follicles in nor-
mal ovaries, CTSS mRNA was abundant in the nodule
area of cancerous ovaries. Further analysis using quanti-
tative RT-PCR indicated that mRNA expression levels
for CTSB, CTSC,a n dCTSS were higher in cancerous
ovaries (P < 0.05, Fig. 5).
Localization of immunoreactive CTSB protein in
cancerous ovaries
We further confirmed the localization of immunoreac-
tive CTSB protein by immunohistochemistry and found
Figure 1 Pathological characteristics of normal and cancerous chicken ovaries. Follicles are hierarchically arranged by stage of
development (F1-F5) in the normal ovary (A). The cancerous ovary has surface tumor lesions and atretic follicles (B). Hematoxylin and eosin
staining of normal (C) and cancerous (D) ovaries from hens. F, follicle; S, stroma; NA, nodule area. Scale bar = 1 cm (A and B) or 100 μm (C and
D).
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( F i g .6 A ) ;h o w e v e r ,C T S Bp r o t e i nw a sd e t e c t e di nt h e
nodule area in cancerous ovaries (Fig. 6B and 6C) which
was consistent with the differential expression of normal
and cancerous ovarian CTSB mRNA (Fig. 4 and 5).
Moreover, CTSB was identified in the cytoplasm of
tumor cells (Fig. 6B) showing different pattern from
staining with anti-PCNA antibody in which PCNA was
identified in nucleus (Fig. 2G and 2H).
Discussion
The mechanisms responsible for the development of
ovarian cancer are not fully understood owing to the
lack of a suitable ovarian cancer animal model [2]. How-
ever, the laying hen has received attention as a model
for ovarian cancer research because of significant simila-
rities between ovarian cancers of hens and women.
Ovarian adenocarcinomas originate predominantly from
the ovarian epithelium and are associated with incessant
ovulation in both species [3,5,27]. The laying hen model
strongly supports the incessant ovulation theory, as hens
ovulate almost every day and exhibit high rates of spon-
taneous development of ovarian adenocarcinoma [6,27].
Also, several anti-tumor antibody antigens (e.g., cytoker-
atin, PCNA, COX-1, COX-2, CEA, AE1/AE3, EGER,
ERBB2, Lewis Y, SELENBP1, p53 and Tag 72) that are
commonly used as markers for human ovarian cancer
Figure 2 Immunohistochemical analysis of normal and cancerous chicken ovaries.P C N A( A ,B ,G ,a n dH ) ,v i m e n t i n( C ,D ,I ,a n dJ ) ,a n d
ERBB2 (E, F, K, and L). In the IgG control, normal mouse IgG was substituted for antibody against each specific antibody. F, follicle; S, stroma; BV,
blood vessel; NA, nodule area; G, gland; GC, granulosa cell; TC, theca cell. Scale bar = 100 μm (A, C, E, G, I, and K) or 25 μm (B, D, F, H, J, and L).
Figure 3 RT-PCR analysis of normal and cancerous chicken
ovaries.
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[6,8,21,23,24,26,28,29].
Proteases, which catalyze the cleavage of peptide
bonds in proteins, can be divided into five categories:
metalloproteases, cysteine proteases, serine proteases,
aspartic proteases, and threonine proteases [30]. CTSs
are a family of cysteine proteases that function primarily
in protein degradation in the lysosomes of the majority
of cell types [11]. However, specific CTSs are often
upregulated in various cancers [31]. CTSs are expressed
at the cell surface of cancer cells and secreted into the
extracellular space, where they degrade ECM
Figure 4 In situ hybridization analysis for cell-specific expression. Frozen sections of normal and cancerous hen ovaries were subjected to
in situ hybridization analysis against sense and/or antisense probes of CTSB, CTSC, and CTSS. There was no mRNA expression detected in the
normal and cancerous ovaries hybridized with sense probes of CTSB, CTSC,o rCTSS. A low level cell-specific localization of CTSB, CTSC,o rCTSS
mRNA was detected in normal ovaries. CTSB mRNA was strongly expressed in the nodule area of cancerous hen ovaries. CTSC and CTSS mRNAs
were also expressed slightly higher level in the gland-like area of cancerous ovaries than that of normal ovaries. F, follicle; NA, nodule area. Scale
bar = 100 μm (columns 1-2 and 4-5) and 25 μm (columns 3 and 6).
Figure 5 Quantitative RT-PCR analysis in normal and cancerous chicken ovaries. Relative expression of CTSB, CTSC,a n dCTSS mRNAs in
normal and cancerous chicken ovaries, showing that the expression of CTSB, CTSC, and CTSS mRNAs was greater in cancerous ovaries (mean ±
SEM; P < 0.05).
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ity allows cancer cells to invade surrounding tissue,
blood, and lymph vessels and to metastasize to tissues at
distant sites [33]. These important roles of CTSs in can-
cer development encouraged us to examine the expres-
sion of CTSs in the chicken ovarian cancer model.
Specific expression of CTSB, CTSC,a n dCTSS was
clearly observed in cancerous ovaries of hens.
Among the CTSs, CTSB has been investigated most
intensively and appears to play a role in cancer based on
its increased expression in various human cancers
[34-36]. A role of CTSB in tumor cell invasion was sug-
gested by the increased invasiveness of cells overexpres-
sing CTSB [37] and by decreased invasion in the
presence of specific inhibitors of CTSB [38]. Women
with ovarian cancer have higher levels of CTSB in their
sera [39], and CTSB is present in ascites and cyst fluid
of patients with ovarian cancer [40,41]. Moreover,
immunohistochemical analysis has shown that CTSB is
evident in the cytoplasm of tumor cells in human ovar-
ian cancer [18,42]. Similarly, the results of the present
study indicate increased expression of CTSB in cancer-
ous, but not normal, chicken ovaries. This suggests that
the role for CSTB in tumor invasion in chickens may be
similar to that in human ovarian cancer.
In addition to CTSB, other CTSs have been proposed
as participants in the angiogenesis and invasion of
tumor cells. For example, Ctss-deficient mice displayed
defective microvessel development during wound repair,
owing to the reduced ability of endothelial cells to
invade the ECM [43]. In a murine model of sporadic
pancreatic carcinogenesis, null mutant Ctsb and Ctss
mice exhibit decreased tumor invasion and angiogenesis
[44,45]. Another study demonstrated that both CTSB
and CTSS are upregulated in the transition from normal
to angiogenic islets and that CTSC is expressed conco-
mitantly with the development of angiogenic islets in
mouse pancreatic islet tumors [46]. In the present study,
the expression of CTSS and CTSC was also detected in
cancerous ovaries of hens, suggesting that CTSS and
CTSC may also play roles in the angiogenesis and inva-
sion of tumor cells.
Conclusions
The results of the present study demonstrate that CTSB,
CTSC,a n dCTSS are upregulated in cancerous ovaries
of chickens, suggesting that CTSB, CTSC, and CTSS
have potentially important functions in the development
of ovarian cancer in chickens. Our study, therefore, pro-
vides a basis for the development of the hen as an ani-
mal model for the study of human ovarian cancer and
for the discovery of the mechanisms responsible for the
development of ovarian cancer.
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